DAFNA Capital Management as of June 30, 2013
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 44 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharmacyclics | 11.9 | $8.1M | 102k | 79.47 | |
| Novadaq Technologies | 9.1 | $6.2M | 461k | 13.46 | |
| AtriCure (ATRC) | 6.6 | $4.5M | 478k | 9.50 | |
| Protalix BioTherapeutics | 6.2 | $4.3M | 868k | 4.91 | |
| Insulet Corporation (PODD) | 5.8 | $3.9M | 125k | 31.41 | |
| Insulet Corporation Cvt 3.75 0 convert | 5.7 | $3.9M | 3.0M | 1.30 | |
| NxStage Medical | 5.3 | $3.6M | 252k | 14.28 | |
| Ariad Pharmaceuticals | 4.9 | $3.3M | 191k | 17.49 | |
| Discovery Laboratories | 3.9 | $2.6M | 1.7M | 1.52 | |
| Cardionet | 3.5 | $2.4M | 402k | 5.90 | |
| Given Imaging | 3.2 | $2.2M | 156k | 14.01 | |
| Dyax | 2.9 | $2.0M | 578k | 3.46 | |
| Curis | 2.6 | $1.8M | 550k | 3.19 | |
| Inspiremd | 2.3 | $1.6M | 715k | 2.21 | |
| Cardica | 1.7 | $1.2M | 1.1M | 1.11 | |
| Achillion Pharmaceuticals | 1.5 | $996k | 122k | 8.18 | |
| Nuvasive Inc. conv | 1.4 | $990k | 1.0M | 0.99 | |
| Spectranetics Corporation | 1.4 | $978k | 52k | 18.68 | |
| XenoPort | 1.4 | $947k | 191k | 4.95 | |
| Venaxis | 1.2 | $836k | 697k | 1.20 | |
| Johnson & Johnson (JNJ) | 1.2 | $807k | 9.4k | 85.85 | |
| BioSpecifics Technologies | 1.2 | $806k | 52k | 15.59 | |
| Baxano Surgical I | 1.2 | $807k | 336k | 2.40 | |
| Syneron Medical Ltd ord | 1.2 | $791k | 91k | 8.70 | |
| Cutera (CUTR) | 1.1 | $781k | 89k | 8.81 | |
| Derma Sciences | 1.1 | $761k | 57k | 13.35 | |
| InfuSystem Holdings (INFU) | 1.0 | $707k | 475k | 1.49 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.0 | $689k | 8.6k | 80.12 | |
| Exactech | 1.0 | $664k | 34k | 19.74 | |
| RTI Biologics | 0.9 | $628k | 167k | 3.76 | |
| Uroplasty | 0.9 | $599k | 289k | 2.07 | |
| Anacor Pharmaceuticals In | 0.9 | $598k | 107k | 5.59 | |
| Keryx Biopharmaceuticals | 0.8 | $575k | 77k | 7.47 | |
| Intercept Pharmaceuticals In | 0.7 | $448k | 10k | 44.80 | |
| Kalobios Pharmaceuticals | 0.7 | $452k | 80k | 5.66 | |
| Masimo Corporation (MASI) | 0.5 | $371k | 18k | 21.20 | |
| Stereotaxis (STXS) | 0.5 | $343k | 222k | 1.55 | |
| Theragenics Corporation | 0.5 | $333k | 161k | 2.07 | |
| Palatin Technologies | 0.5 | $319k | 515k | 0.62 | |
| Graymark Healthcare | 0.2 | $146k | 693k | 0.21 | |
| Cyclacel Pharmaceuticals | 0.2 | $131k | 44k | 2.96 | |
| Authentidate Holding | 0.2 | $124k | 142k | 0.87 | |
| Digirad Corporation | 0.1 | $89k | 37k | 2.43 | |
| Combimatrix Corporation *w exp 05/01/ | 0.0 | $999.750000 | 2.3k | 0.43 |
